Market revenue in 2020 | USD 15.9 million |
Market revenue in 2027 | USD 25.2 million |
Growth rate | 6.8% (CAGR from 2020 to 2027) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Instruments |
Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 67.3% in 2020. Horizon Databook has segmented the UAE blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
The UAE is the most technologically advanced region in the Middle East and this is reflected in blood transfusion diagnostics market. SEHA is a key player in healthcare domain as it owns and operates the public hospitals in Abu Dhabi.
The organization operates over 52,000 blood units in Abu Dhabi and AI Ain and recently introduced a new blood center in the Al Dhafra region. In May 2021, SEHA collaborated with the Department of Health Abu Dhabi to open a new blood donation center in Zayed City and hold receiving capacity of 3,000 donors per year.
The same partnership also launched a project on frozen red blood cells in January 2021. This project aims to ensure existence of blood supply in blood banks by implementing new technologies to freeze 600 units every year for over 5 years and meet urgent blood transfusion demand. Blood transfusion is a niche and competitive market in Saudi Arabia.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into UAE blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account